CODX

Co-Diagnostics, Inc. Common Stock

CODX.US co-dx.com + Research + Basket
CIK 0001692415
Employees 115
Phone 801 438 1036
Fiscal year end December
IPO Jul 12, 2017
Address 2401 S. Foothill Drive, Salt Lake City, UT, United States, 84109
0.38
-0.01 (-2.54%)
USD · NASDAQ
52-week range
0.39
13.80
Trading at 0% of the 52-week range
Market Cap
3.48M
P/E Ratio
0.00
Forward P/E
15.36
Book Value
2.61
Div. Yield
N/A
% Institutions
7.47%
% Insiders
8.36%

1 Year

-97.3%

3 Year

-98.8%

10 Year

-99.8%
Description

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.

Actions

Add an action for CODX.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Dwight H. Egan Chairman, CEO & President 1953
Mr. Richard David Abbott President 1972
Mr. David Nielsen Chief Operating Officer NA
Mr. Christopher Thurston Chief Technology Officer NA
Dr. Wesley C. Lindsey MBA, Ph.D. Chief Scientific Officer NA
Dr. Mayuranki Almaula Ph.D. Senior Vice President of Overseas Operations & Strategic Alliances NA
Mr. Seth Egan Chief Commercialization Officer & Strategy Officer NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Mar 20, 2023 Brian Lee Brown N/A Purchase 100.00 $57.00 $5.70K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Armistice Capital, LLC 236.00K Jun 30, 2026 3.38% $0.01 0.00%
Jane Street Group LLC 89.24K Jun 30, 2026 1.28% $0.00 0.00%
Vanguard Capital Management, LLC 58.28K Jun 30, 2026 0.83% $0.00 0.00%
Private Asset Group LLC 39.39K Jun 30, 2026 0.56% $0.01 -4.83%
Millennium Management LLC 32.00K Jun 30, 2026 0.46% $0.00 0.00%
Susquehanna International Group, LLP 31.24K Jun 30, 2026 0.45% $0.00 0.00%
Geode Capital Management, LLC 25.58K Jun 30, 2026 0.37% $0.00 0.00%
Vanguard Fiduciary Trust Co 19.78K Jun 30, 2026 0.28% $0.00 1,977,500.00%
Virtu Financial LLC 17.61K Jun 30, 2026 0.25% $0.00 0.00%
UBS Group AG 16.09K Jun 30, 2026 0.23% $0.00 118.39%
State Street Corp 14.80K Jun 30, 2026 0.21% $0.00 0.00%
Renaissance Technologies Corp 12.50K Jun 30, 2026 0.18% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 2.88K Jun 30, 2026 0.04% $0.00 3,169.32%
Global Retirement Partners, LLC. 100.00 Jun 30, 2026 0.00% $0.00 0.00%
Wells Fargo & Co 81.00 Jun 30, 2026 0.00% $0.00 0.00%
SBI Securities Co Ltd 81.00 Jun 30, 2026 0.00% $0.00 39.66%
Heritage Wealth Advisors, LLC 17.00 Jun 30, 2026 0.00% $0.00 0.00%
Western Wealth Management, LLC 17.00 Mar 31, 2026 0.00% $0.00 0.00%
Advisor Group Holdings, Inc. 10.00 Jun 30, 2026 0.00% $0.00 0.00%
FMR Inc 7.00 Jun 30, 2026 0.00% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 32.99K 0.47% ▲ 73.57% Aug 31, 2026
2 Fidelity Series Total Market Index 6.57K 0.09% ▲ 0.00% Aug 31, 2026
3 Fidelity Total Market Index 4.34K 0.06% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $3.48M
EBITDA: $-29.09M
PEG Ratio: $0.00
Book Value: $2.61
Earnings/Share: $-26.14
Profit Margin: 0.00%
Operating Margin: -3,732.47%
ROA (TTM): -59.63%
ROE (TTM): -174.77%
Revenue (TTM): $721.39K
Revenue/Share (TTM): $0.30
Earnings Growth (YOY): 30.80%
Revenue Growth (YOY): 2.00%

Valuation Metrics

Enterprise Value: $1.63M
Trailing P/E: 0.00
Forward P/E: 15.36

Shares Statistics

Shares Outstanding: 8.82M
Shares Float: 6.16M
% Insiders: 8.36%
% Institutions: 7.47%
Shares Short: 656.37K
Shares Short (Prior Month): 418.93K
Short Ratio: 1.62
Short % Float: 8.79%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$622.49K
Cost of Goods Sold
adjust
$-222.38K
Gross Profit
subtotal
$400.11K
SG&A
adjust
$-9.06M
R&D
adjust
$-19.14M
Other Operating Expense
adjust
$-3.49M
Operating Income
subtotal
$-31.28M
Other / Non-Operating Items
adjust
$-15.61M
Net Income
subtotal
$-46.90M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CODX.US!